Literature DB >> 16765451

"Dirty little secrets"--endotoxin contamination of recombinant proteins.

Sonia J Wakelin1, Ian Sabroe, Christopher D Gregory, Ian R Poxton, John L R Forsythe, O James Garden, Sarah E M Howie.   

Abstract

The identification of Toll-like receptors has revolutionised our understanding of innate immunity. TLR4 transduces the LPS signal and that of a number of structurally and functionally unrelated agonists. However, recent evidence adds to longstanding concerns that endotoxin contamination of bacterially derived recombinant TLR4 agonists is responsible for effects attributed to these molecules. We highlight key factors in differentiating specific agonist effects from those of endotoxin and emphasize why conventional methods of detecting and eliminating LPS may lead to erroneous results. We propose that considerable caution is needed in the investigation of TLR4 agonists, particularly when using proteins produced in a bacterium that also houses the most ideal TLR4 agonist, LPS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765451     DOI: 10.1016/j.imlet.2006.04.007

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  30 in total

Review 1.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

Review 2.  Planning, evaluating and vetting receptor signaling studies to assess hyaluronan size-dependence and specificity.

Authors:  Paul H Weigel
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

3.  Contamination of a recombinant hepatitis B virus nucleocapsid preparation with a human B-cell activator.

Authors:  Peter Vanlandschoot; Freya Van Houtte; Benedikte Serruys; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

4.  Tethering transforming growth factor β1 to soft hydrogels guides vascular smooth muscle commitment from human mesenchymal stem cells.

Authors:  Yonghui Ding; Richard Johnson; Sadhana Sharma; Xiaoyun Ding; Stephanie J Bryant; Wei Tan
Journal:  Acta Biomater       Date:  2020-01-23       Impact factor: 8.947

Review 5.  Consensus guidelines for the use and interpretation of angiogenesis assays.

Authors:  Patrycja Nowak-Sliwinska; Kari Alitalo; Elizabeth Allen; Andrey Anisimov; Alfred C Aplin; Robert Auerbach; Hellmut G Augustin; David O Bates; Judy R van Beijnum; R Hugh F Bender; Gabriele Bergers; Andreas Bikfalvi; Joyce Bischoff; Barbara C Böck; Peter C Brooks; Federico Bussolino; Bertan Cakir; Peter Carmeliet; Daniel Castranova; Anca M Cimpean; Ondine Cleaver; George Coukos; George E Davis; Michele De Palma; Anna Dimberg; Ruud P M Dings; Valentin Djonov; Andrew C Dudley; Neil P Dufton; Sarah-Maria Fendt; Napoleone Ferrara; Marcus Fruttiger; Dai Fukumura; Bart Ghesquière; Yan Gong; Robert J Griffin; Adrian L Harris; Christopher C W Hughes; Nan W Hultgren; M Luisa Iruela-Arispe; Melita Irving; Rakesh K Jain; Raghu Kalluri; Joanna Kalucka; Robert S Kerbel; Jan Kitajewski; Ingeborg Klaassen; Hynda K Kleinmann; Pieter Koolwijk; Elisabeth Kuczynski; Brenda R Kwak; Koen Marien; Juan M Melero-Martin; Lance L Munn; Roberto F Nicosia; Agnes Noel; Jussi Nurro; Anna-Karin Olsson; Tatiana V Petrova; Kristian Pietras; Roberto Pili; Jeffrey W Pollard; Mark J Post; Paul H A Quax; Gabriel A Rabinovich; Marius Raica; Anna M Randi; Domenico Ribatti; Curzio Ruegg; Reinier O Schlingemann; Stefan Schulte-Merker; Lois E H Smith; Jonathan W Song; Steven A Stacker; Jimmy Stalin; Amber N Stratman; Maureen Van de Velde; Victor W M van Hinsbergh; Peter B Vermeulen; Johannes Waltenberger; Brant M Weinstein; Hong Xin; Bahar Yetkin-Arik; Seppo Yla-Herttuala; Mervin C Yoder; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2018-08       Impact factor: 9.596

Review 6.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

7.  Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity.

Authors:  Lysann Schädlich; Tilo Senger; Britta Gerlach; Norbert Mücke; Corinna Klein; Ignacio G Bravo; Martin Müller; Lutz Gissmann
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

8.  Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.

Authors:  Rúbens Prince Dos Santos Alves; Lennon Ramos Pereira; Denicar Lina Nascimento Fabris; Felipe Scassi Salvador; Robert Andreata Santos; Paolo Marinho de Andrade Zanotto; Camila Malta Romano; Jaime Henrique Amorim; Luís Carlos de Souza Ferreira
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

9.  Transient expression of human antibodies in mammalian cells.

Authors:  Rodrigo Vazquez-Lombardi; Damien Nevoltris; Ansha Luthra; Peter Schofield; Carsten Zimmermann; Daniel Christ
Journal:  Nat Protoc       Date:  2017-12-14       Impact factor: 13.491

10.  An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.

Authors:  Guangyu Zhao; Yongping Lin; Lanying Du; Jie Guan; Shihui Sun; Hongyan Sui; Zhihua Kou; Chris Cs Chan; Yan Guo; Shibo Jiang; Bo-Jian Zheng; Yusen Zhou
Journal:  Virol J       Date:  2010-01-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.